Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology TrialsChristopher L. Hallemeier, Christopher H. Crane, Kenneth L. Zeitzer et al.|JAMA Network Open|2023Cited by 17
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical TrialsChristopher L. Hallemeier, Howard M. Sandler, Peixin Zhang et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 13
Impact of radiotherapy duration on outcomes in patients with esophageal cancer treated with definitive concurrent radiotherapy and chemotherapy on RTOG trials 8501 and 9405.Christopher L. Hallemeier, Christopher H. Crane, Jennifer Moughan et al.|Journal of Clinical Oncology|2015Cited by 0